Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q2 EPS of ($0.67), $0.05 worse than the analyst estimate of ($0.62). Revenue for the quarter came in at $6.2 million versus the consensus estimate of $6.2 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.